University Health Network - Princess Margaret Cancer Centre
Related Team Members
-
Aaron
Research Lead
Schimmer -
Amit
Researcher
Oza -
Ben
ResearcherWorking Group Member
Wang -
Benjamin
ResearcherWorking Group Member
Haibe-Kains -
Bradly
MOHCCN Network CouncilConsortium Leader
Wouters -
Luke
Researcher
Brzozowski -
Tracy
Researcher
Stockley -
Trevor
ResearcherProject LeaderWorking Group ChairWorking Group Member
Pugh -
Sevan
Project Manager
Hakgor -
Philippe
Project LeaderMOHCCN Network CouncilWorking Group Member
Bedard -
Stéphanie
Project Leader
Lheureux -
Ming-Sound
Research LeadWorking Group Member
Tsao -
Jennifer
Project Leader
Knox -
Scott
Project LeaderWorking Group Member
Bratman -
Anna
Project Leader
Spreafico -
Gonzalo
Project Leader
Sapisochin -
Anand
Project Leader
Ghanekar -
Robert
Project Leader
Kridel -
Steven
Project Leader
Gallinger -
Aaron
Project Leader
Hansen -
Geoffrey
Project Leader
Liu -
Raymond
Project LeaderWorking Group Member
Kim -
Housheng
Project Leader
He -
Alejandro
Project Leader
Berlin -
Theodorus
Project Leader
van der Kwast -
Michael
MOHCCN Steering CommitteeResearcher
Brudno -
Lillian
MOHCCN Steering CommitteeInstitutional LeadConsortium LeaderWorking Group ChairWorking Group MemberResearcher
Siu -
Sophie
Project Manager
Cooke -
Emily
Project ManagerWorking Group ChairWorking Group Member
Van de Laar -
Karen
ResearcherWorking Group Member
Cranston -
Lesley
MOHCCN Network CouncilWorking Group Chair
Rapaport -
Aileigh
Project ManagerWorking Group Member
Kay -
Prabhjit
Project Manager
Basra -
Long
Researcher
Nguyen -
Robert
Researcher
Grant -
Faiyaz
Researcher
Notta -
Grainne
Researcher
O'Kane -
Pavlina
Researcher
Spiliopoulou -
Igor
Researcher
Novitzky-Basso -
Alberto
Researcher
Hernando-Calvo -
Marcus
Researcher
Butler -
Samuel
Researcher
Saibil -
Farnoosh
Researcher
Abbas-Aghababazadeh -
Nikta
Researcher
Feizi -
Caryn
Researcher
Geady -
Michael
Researcher
Geuenich -
Peter
Researcher
Her -
Pamela
ResearcherWorking Group Member
Ohashi -
David
Researcher
Cescon -
David
Researcher
Brooks -
Tracy
Researcher
McGaha -
Linh
Researcher
Nguyen -
John
Researcher
Kuruvilla -
Rob
Researcher
Laister -
Anca
Researcher
Prica -
Eric
Researcher
Chen -
Ian
Researcher
McGilvray -
Robert
Researcher
Beecroft -
John
Researcher
Kachura -
Daniel
Researcher
De Carvalho -
Vikas
Researcher
Gupta -
Neil
Researcher
Fleshner -
Suzanne
Researcher
Trudel -
Xin Kevin
Researcher
Wang -
Susan
Researcher
Done -
Erica
Researcher
Tsang -
Mark
Working Group Chair
Minden -
Enrique
Researcher
Sanz -
Natasha
Researcher
Leighl -
Julia
Researcher
Nguyen -
Yuanchang
Researcher
Fang -
David
Researcher
Henault -
Robert
Researcher
Rottapel -
Robert
Researcher
Vanner -
Hal
Researcher
Berman -
Mathieu
Researcher
Lupien
Projects
-
Neoadjuvant precision therapy for non-small cell lung cancer: A platform for discovery
Tracking immunotherapy response to personalize treatment for lung cancer patients -
Canadian Head And Neck cancer GEnomic (CHANGE) Collaborative
Understanding the molecular underpinnings of high recurrence rates in oral squamous cell carcinoma to improve survival and quality of life for patients -
Canadian framework to improve predictive models for immunotherapy interventions (CAN-PREDICT-IT)
Developing multi-modal biomarkers to predict response to specific immunotherapies -
Targeting clonal hematopoiesis to prevent hepatocellular carcinoma
Targeting inflammation to prevent hepatocellular carcinoma -
Comprehensive deciphering of the genetic, epigenetic and immunogenetic mechanisms of post-allogeneic transplant relapse in acute myeloid leukemia
Uncovering the secrets of post-transplant relapse in acute myeloid leukemia -
Orthogonal pangenome sequencing to unveil genetic cancer susceptibility diagnostic odysseys: a Return of Results Working Group new technology assessment study
Using long-read sequencing to reveal unknown hereditary links to cancer -
Plasma whole genome sequencing in pancreatic and biliary cancers
Advancing plasma whole genome sequencing to better treat and monitor patients with pancreatic and biliary cancers -
Deciphering heterogeneity of rare metaplastic breast carcinoma Gold Cohort through spatialomics
Pan-Canadian team will use new funding to better understand rare breast cancers -
Metabolomics standardization process
Pioneering metabolomic assessments to accelerate precision oncology for ovarian cance
Related News
-
Marathon of Hope Cancer Centres Network operational plan continues to take shape
Stakeholders from partner institutions across Canada are meeting on a regular basis to operationalize the Marathon of Hope Cancer Centres Network. -
Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada
The TFRI and Health Canada have signed a contribution agreement that allows the Marathon of Hope Cancer Centres Network to begin operating. This has allowed us to designate the first members of the ne... -
PM2C hosts second event in the MOHCCN Seminar Series
This talk was given on Dec. 6th, 2021 as part of the Marathon of Hope Cancer Centres Seminar Series. -
Four outstanding clinician-scientists named inaugural Clinician-Scientist Awardees following Marathon of Hope Cancer Centres Network competition
Four early-career clinician-scientists in Alberta, Ontario and Quebec are the first recipients of the inaugural Clinician-Scientist Award funded by the Marathon of Hope Cancer Centres Network (MOHCCN)... -
MOHCCN Pathfinder Project clears the way for future data sharing between Network members
Through its Pathfinder Project, the MOHCCN has developed and deployed a technical tool that allows members to upload, discover – and eventually access – the data needed to accelerate precision medicin... -
Four early-career MOHCCN Clinician-Scientist Award holders focus on accelerating precision medicine for patients with gynecologic, blood, breast and head and neck cancers
This new injection of funding totaling $1.8M will support research for gynecologic, head and neck, blood and breast cancers, with three of the projects based in Quebec and one in Ontario. -
Eight early-career data scientists named inaugural Health Informatics & Data Scientist Awardees following MOHCCN competition
Awardees will use the funds to support clinically related research using MOHCCN data, providing information that may form the basis of innovative cancer prevention, diagnosis and/or treatment. -
MOHCCN Pan-Canadian Projects underway with announcement of first grant recipients
In total, the Network will fund 20 such groups, representing a multi-million-dollar investment over the next three years that will contribute roughly 6,000 cases to the MOHCCN Gold Cohort, the largest... -
Leadership and researchers at the Princess Margaret Cancer Consortium present updates to Network
The presentation was part of MOHCCN Seminar Series, which features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing... -
MOHCCN announces second group of projects to receive funding through the Pan-Canadian Projects program
The Marathon of Hope Cancer Centres Network is happy to introduce the second group of projects to receive funding through its newly created Pan-Canadian Projects program. This program, which expands o... -
The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu on being elected president of the American Association for Cancer Research
The Terry Fox Research Institute and the Marathon of Hope Cancer Centres Network congratulate Dr. Lillian Siu, member of the MOHCCN Steering Committee and lead of the Princess Margaret Cancer Consorti... -
Marathon of Hope Cancer Centres Network tackles rare cancers in its Roadmap to Cure Cancer
Two multi-disciplinary research teams will come together for the first time to tackle two forms of rare cancer thanks to new funding from the Marathon of Hope Cancer Centres Network. Two multi-disciplinary research teams will come together for the first time to tackle two forms of rare cancer thanks to new funding from the Marathon of Hope Cancer Centres Network. -
Four new pan-Canadian research teams join the Team Canada of Cancer Research
Today’s announcement raises the number of announced projects funded through this program to 12. In total, the Network will fund 20 such groups, representing a multi-million-dollar investment over the ... -
Marathon of Hope Cancer Centres Network and Canadian Cancer Trials Group partner on three pan-Canadian projects aimed at making immunotherapy more effective for cancer patients
A new partnership between the Marathon of Hope Cancer Centres Network (MOHCCN) and the Canadian Clinical Trials Group (CCTG) will support three pan-Canadian research teams aiming to better understand ... -
Network names 10 early-career data scientists as recipients of its 2024 Health Informatics & Data Science Awards
Each will receive $40,000 from the Network over the next year to be matched by their host institutions for a total of $80,000 to support groundbreaking research in precision oncology. -
Network names four outstanding early-career clinician-scientists as recipients of its 2024 MOHCCN Clinician-Scientist Awards
Four promising, early-career clinician-scientists from Alberta, Ontario and Quebec have been named recipients of the 2024 Clinician-Scientist Awards, funded by the Marathon of Hope Cancer Centres Netw... -
Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards
New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer Eight outstanding research teams from across the country will receive a total of $2.2M from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer Centres Network (MOHCCN) to develop,... -
PM2 CAN-IMPACT-IO a national immunotherapy biospecimen collection study has now opened
PM2 CAN-IMPACT-IO is a unique national initiative to measure, predict and assess cancer treatment outcomes in patients who have been treated with immunotherapy. Patients on CCTG clinical trials who co...
-
Regional Consortia
Princess Margaret Cancer Consortium
- Ontario
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...Read more